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Background: Non-celiac wheat sensitivity is an emerging wheat-related syndrome showing peak prevalence in
Western populations. Recent studies hypothesize that new gliadin alleles introduced in the human diet by
replacement of ancient wheat with modern varieties can prompt immune responses mediated by the
CXCR3-chemokine axis potentially underlying such pathogenic inflammation. This cultural shift may also explain
disease epidemiology, having turned European-specific adaptive alleles previously targeted by natural selection into
disadvantageous ones.
Methods: To explore this evolutionary scenario, we performed ultra-deep sequencing of genes pivotal in the
CXCR3-inflammatory pathway on individuals diagnosed for non-celiac wheat sensitivity and we applied
anthropological evolutionary genetics methods to sequence data from worldwide populations to investigate the
genetic legacy of natural selection on these loci.
Results: Our results indicate that balancing selection has maintained two divergent CXCL10/CXCL11 haplotypes in
Europeans, one responsible for boosting inflammatory reactions and another for encoding moderate chemokine
expression.
Conclusions: This led to considerably higher occurrence of the former haplotype in Western people than in
Africans and East Asians, suggesting that they might be more prone to side effects related to the consumption of
modern wheat varieties. Accordingly, this study contributed to shed new light on some of the mechanisms
potentially involved in the disease etiology and on the evolutionary bases of its present-day epidemiological
patterns. Moreover, overrepresentation of disease homozygotes for the dis-adaptive haplotype plausibly accounts
for their even more enhanced CXCR3-axis expression and for their further increase in disease risk, representing a
promising finding to be validated by larger follow-up studies.
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Non-celiac gluten sensitivity was defined as a new inde-
pendent and emerging wheat-related syndrome with re-
spect to celiac disease (CD), irritable bowel syndrome
(IBS), or wheat allergy (WA) [1, 2], showing a rapidly
evolving trend especially in the Western world [1, 3, 4].
Recently, other wheat proteins in addition to gluten have
been proposed to play a role in the development of such
pathogenic condition so that it has been suggested to re-
classify it as non-celiac wheat sensitivity (NCWS) [5].
Nevertheless, it remains to be elucidated whether the
substantial rise of disease prevalence in Western popula-
tions [3, 6] is the result of increased awareness and
reporting/diagnosis or is actually due to its increasing
diffusion in such human groups.
NCWS still has an undefined etiology, and its diagnosis is
based on the exclusion of IgE-mediated WA and of CD by
negative serological CD markers (i.e., anti-endomysium
antibodies, anti-EmA and anti-tissue transglutaminase anti-
bodies, and anti-tTG) [1]. However, although biomarkers of
immune response to gluten (e.g., IgG anti-gliadin anti-
bodies, AGA) can be observed in 56–66 % of NCWS cases,
a pivotal role of innate immunity in the development of the
disease is widely accepted [7, 8].
The role that wheat (Triticum spp.) proteins play in
determining our health has been accurately dissected, and
different studies have shown that CD has increased two- to
fourfold over the last 50 years [9, 10]. The causes of this re-
cent CD increase have not been fully determined, but sev-
eral authors have suggested that the last six decades of
industry-driven breeding produced wheat varieties with
more reactive proteins [11, 12]. This hypothesis is highly
consistent with overexpression of CXCL10 (a CXCR3
ligand) induced in peripheral blood mononucleated cells
from NCWS patients by contact with proteins of modern
wheat, but not by contact with proteins of ancient wheat
varieties [13]. In addition to this, it has been reported that
different Th1-associated interferon gamma (IFN-γ) expres-
sion is present in NCWS with respect to CD [14]. Interest-
ingly, several IFN-γ-related chemokine ligands bind also to
the CXCR3 receptor, playing a key role in the perpetuation
of inflammation [15], and the whole CXCR3 axis has been
found to be significantly overexpressed in inflammatory
bowel disease and other inflammatory phenotypes [16, 17].
Moreover, some single nucleotide polymorphisms (SNPs)
at the related genes were found to exert protein expression-
regulating effects that can lead to altered IFN-γ pathway
[17–19]. Since CXCR3 has been proposed to bind also glia-
dins [20], it could be hypothesized that gluten itself may
trigger an initial innate challenge able to further induce se-
cretion of CXCR3 chemokine ligands and to establish a vi-
cious cycle that results in amplified Th1-type inflammation.
According to this evidence, variation at genes playing
a pivotal role in the CXCR3 inflammatory pathwaymight contribute to disease etiology, albeit no studies
have investigated this issue so far, thus preventing identi-
fication of possible NCWS genetic determinants. For this
purpose, and to contribute to the dissection of NCWS’s
main causes and pathogenic mechanisms, we aimed at
providing new insights into the evolutionary history of such
disease by applying anthropological genetics methods. The
rationale underlying this approach moves from the observa-
tion that even if NCWS prevalence is still far from being
accurately determined, it substantially varies among human
groups with different ancestry, with peaks of 3–6 % re-
ported by Italian and US referral centers for gluten-related
disorders [3, 21]. In some populations, NCWS thus would
occur up to six times more than CD, which shows a preva-
lence of approximately 1 %. This suggests that various
selective pressures having acted on diverse human groups,
and in different ways during their early and recent evolu-
tionary history, might explain high and changing worldwide
NCWS prevalence. Certainly, such epidemiological pattern
is in part due to the different extent of cereal consumption
in diverse human societies (i.e., divergent degree of expos-
ure to gluten), although the ever-increasing globalization of
human diets should have reshaped this picture towards
reduced inter-population differences in disease prevalence.
The fact that NCWS occurrence still remains considerably
higher in Western populations suggests that its susceptibil-
ity extensively varies among human groups also as a conse-
quence of their genetic background. In particular, it can be
hypothesized that populations of European ancestry retain
NCWS risk variants at appreciable frequency in their gene
pools plausibly due to the adaptive role exerted by these
alleles in their early history. In fact, by modulating inflam-
matory reactions, these variants could have favored adapta-
tion of these human groups to highly challenging pathogen
landscapes, such as those characterizing the European con-
tinent, especially after Neolithic transition [22]. The very
recent replacement of ancient wheat with modern dwarf
varieties highly selected for improving industrial productiv-
ity might have then represented a sudden dietary shift that
has turned these past genetic adaptations into disadvanta-
geous maladaptive traits, triggering increased susceptibility
of present-day Europeans to NCWS. In fact, different from
what occurred in the last 8500 years of human wheat
cultivation, contemporary breeding programs have been
strongly addressed to enhance gluten strength and visco-
elasticity in order to enable dough to tolerate high
stresses during mixing and leavening mechanized pro-
cesses [23, 24]. This gain in wheat technological proper-
ties was thus achieved to meet industrial requirements
and by specifically selecting protein quality in terms of
gliadin and glutenin allelic variants, rather than by con-
sidering wheat toxic potential [25]. Unfortunately, the
selected protein profiles are characterized by specific
immune-stimulatory epitopes that have been proved to
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increased chemokine secretion and mucosal immune cells
infiltration) with respect to those related to wheat ances-
tors or early domesticated species [13, 26–29].
To explore this complex scenario and the mechanisms
potentially underlying the described maladaptive process,
we investigated the genetic legacy of natural selection on
major genes involved in the CXCR3 inflammatory path-
way in several worldwide populations as well as in a well-
characterized sample of NCWS subjects. This enabled to
pinpoint past pathogen-driven adaptive events that could
have made individuals of European ancestry more prone
to the side effects related to the consumption of modern
wheat varieties. Therefore, the obtained results promise to
contribute to shed light on some of the main mechanisms
plausibly responsible for NCWS etiology, as well as on the
evolutionary bases of its present-day epidemiological
patterns.
Methods
Schematic representation of the implemented research
approach is described as a flowchart detailing the adopted
steps for NCWS sample selection as well as the popula-
tion genetic analytical workflow aimed at identifying sig-
natures of past natural selection that could be implicated
in increased disease susceptibility of some present-day
human populations (Additional file 1: Figure S1).
NCWS samples
The present study involved 18 unrelated individuals (i.e.,
14 females and 4 males with a median age of 38 years and
range of 22–56 years) diagnosed as having NCWS after a
thorough evaluation. All subjects were of Italian origins,
and their genetic ancestry was further tested by evaluating
concordance of ancestry components at the examined
genes with those observed in Western European popula-
tions. They complained of one or more gastrointestinal
(e.g., bloating, abdominal pain, diarrhea/constipation, nau-
sea, epigastric pain, gastro-esophageal reflux, and aphthous
stomatitis) and extra-intestinal (e.g., tiredness, headache,
joint/muscle pain, arm numbness, “foggy mind,” derma-
titis/skin rash, anxiety, depression, and anemia) symptoms
with an early onset (i.e., a few hours or days) after gluten
ingestion. CD was ruled out in all patients by negativity for
tTG and EmA, as well as by the absence of villous atrophy
in the duodenal biopsy (Marsh classification 0 or 1),
whereas WA was excluded by negativity for specific IgE
antibodies to wheat and/or skin prick tests. An open oral
wheat challenge was then performed to confirm the clinical
suspicion of NCWS.
Informed consent was obtained from all individual
participants included in the study, and the study was
designed in accordance with the ethical standards of the
local independent institutional ethical committee andwith the Helsinki Declaration and its later amendments
or comparable ethical standards.Investigated genomic regions
Genes playing a pivotal role in the CXCR3 chemokine lig-
and-dependent inflammatory pathway have been searched
by literature survey and by exploring known and predicted
functional interactions between the CXCR3 receptor and
all its possible ligands reported in the STRING database
v.9.1 [30], finally focusing on loci characterized by
extremely high confidence scores (CS) (i.e., CS > 0.99).
Accordingly, the CXCR3, CXCL9, CXCL10, and CXCL11
genes were selected and their genomic coordinates were
submitted to the Ion AmpliSeq™ Designer tool (Life Tech-
nologies, Grand Island, NY, USA). This approach enabled
to design two different primer pools for the amplification
of a genomic interval covering 14.8 kb and including the
exonic, intronic, and 2-kb 5′ and 3′ flanking regions of
the examined genes.DNA libraries’ preparation and sequencing
DNA was extracted from NCWS blood samples using the
QIAamp DNA kit (QIAGEN GmbH, Hilden, Germany)
and quantified with the Qubit® dsDNA BR Assay Kit
(Invitrogen™ Life Technologies, Carlsbad, CA, USA) for
Qubit 2.0 Fluorometer.
Library preparation was carried out using the designed
primer pools and the Ion AmpliSeq Library Kit 2.0 (Life
Technologies, Grand Island, NY, USA), according to the
manufacturer’s instructions and using 10 ng of DNA.
Ligation of barcodes on the 110 obtained amplicons was
performed by means of the Ion Xpress™ Barcode Kit
(Life Technologies, Grand Island, NY, USA), whereas
Agencourt® AMPure® XP Reagent Kit (Beckman Coulter,
Beverly, MA, USA) and Ion Library Quantitation Kit
(Life Technologies, Grand Island, NY, USA) were used
to purify and quantify amplicons by means of qPCR with
a StepOnePlus™ Real-Time PCR System (Life Technolo-
gies, Grand Island, NY, USA).
Purified fragments were diluted to 8 pM, pooled, and
used to prepare DNA templates with the Ion PGM™
Template OT2 200 Kit (Life Technologies, Grand Island,
NY, USA) on an Ion OneTouch™ 2 System (Life Technolo-
gies, Grand Island, NY, USA). Template-positive ion
sphere particles (ISPs) were then retrieved and submitted
to template enrichment using Dynabeads® MyOne™ Strep-
tavidin C1 magnetic beads (Life Technologies, Grand
Island, NY, USA) on an Ion OneTouch™ ES instrument
(Life Technologies, Grand Island, NY, USA) according to
the manufacturer’s instructions.
Enriched DNA libraries were finally sequenced on an
Ion PGM™ platform (Life Technologies, Grand Island, NY,
USA) by means of two Ion 314™ Chip runs and using the
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Sequence alignment and variant calling
The TMAP tool of the Torrent Suite™ v. 4.0.2 (Life Tech-
nologies, Grand Island, NY, USA) was used to perform
polyclonal, low-quality and primer dimer quality control
(QC) filters, as well as barcode splitting and primers trim-
ming, and to map the high-quality sequence reads to the
reference sequences of each examined gene, thus produ-
cing the BAM files used for subsequent analyses.
SNPs and insertion/deletion (INDELs) calling was car-
ried out using the germ-line pipeline of the Ion Torrent
Variant Caller Plugin v. 4.0 (Life Technologies, Grand
Island, NY, USA) that implements a frequentist ap-
proach for dealing with high coverage (>60×) genomic
positions and a Bayesian method for dealing with loci
showing low to medium coverage (10–50×).
In order to control for false-positive calls, especially
INDELs, resulting from sequencing errors due to the pres-
ence of homopolymers in the analyzed genomic regions,
variant calling was validated by means of a separate pipe-
line based on widely used bioinformatics tools imple-
mented in the Galaxy platform [31, 32]. The adopted
workflow included the following steps, each one per-
formed with ad hoc configuration: (i) sequence reads QC;
(ii) removal of low-quality portions of reads; (iii) align-
ment to the hg19 human reference genome; (iv) selection
of target aligned regions; and (v) variant calling. In details,
QC was performed using the FastQC toolset [33] and
reads were trimmed at the position where the evaluated
median quality score dropped below 26. Alignment was
performed using BWA with default parameters [34], and
the resulting SAM file was converted into BAM format
and sliced by selecting only reads mapping on the regions
of interest specified by a BED file. Variant calling was then
obtained by means of the mpileup tool implemented in
the SAM tool package [35] and using default parameters
coupled with a coefficient for modeling homopolymer-
related sequencing errors of 40. The obtained VCF file
was finally filtered maintaining only variants with quality
values equal or above 100.
Reference dataset
To perform population genetics analyses, a reference data-
set made up of 836 individuals belonging to nine human
groups was constructed by collecting sequence data gener-
ated by the 1000 Genomes Project [36]. In particular,
populations characterized by limited genetic admixture
were selected to be sufficiently representative of African
(i.e., Yoruba from Nigeria, YRI; Luhya from Kenya, LKW),
European (i.e., Tuscans from Italy, TSI; Utah residents
with Northern and Western European ancestry, CEU;
British from England and Scotland, GBR; Finnish, FIN),and East Asian (i.e., Han Chinese from Beijing, CHB; Han
Chinese from Southern China, CHS; Japanese from Tokyo,
JPT) variation at the examined genes.
Population structure and differentiation analyses
Worldwide patterns of population structure at the se-
quenced genomic regions were explored using a pruned
subset of SNPs in approximate linkage equilibrium with
each other to prevent achievement of biased results for
the applied multivariate analyses due to linkage disequi-
librium (LD). For this purpose, the reference dataset was
filtered using the PLINK package v.1.07 [37] to prune
SNPs in LD by using a sliding window approach.
Windows of 50 SNPs, with LD being calculated between
each possible pair of SNPs, were used, and one of a pair
of SNPs was removed if pairwise genotypic correlation
(r2) was greater than 0.1. Each window subsequently
shifted 10 SNPs forward, and the same procedure was
repeated.
Discriminant analysis of principal components (DAPC)
[38], which is particularly well suited for depicting genetic
relationships among pre-defined groups of observations,
was applied to the pruned dataset using the R adegent
package. Once calculated principal components (PCs),
DAPC was repeated with different randomized groups for
different amounts of retained PCs, whose optimal number
was identified as that optimizing the mean α-score (i.e.,
the closest to 1) obtained as the difference between
observed and random discriminations. Retained PCs were
passed to a linear discriminant analysis that constructed
discriminant functions as linear combinations of original
variables in order to show the largest between-group
variance and the smallest within-group one. Given the low
number of examined groups, all discriminant functions
were retained to perform the analysis.
NCWS samples were subsequently represented onto
the obtained discriminant functions as supplementary
individuals (i.e., observations which do not actually
participate to model construction, but which can be
predicted using the model fitted on the reference data-
set). In fact, NCWS data were transformed using center-
ing and scaling of the reference dataset and according to
the same discriminant coefficients as for contributing
healthy individuals. Evaluation of posterior membership
probabilities for both healthy and NCWS subjects to
belong to a given group was finally achieved and repre-
sented in an admixture-like plot.
To point out SNPs mainly driving the observed patterns
of population structure, differentiation among clusters of
genetically homogeneous populations grouped according
to DAPC results (i.e., Africans, AFR; Europeans, EUR; East
Asians, EAS) was investigated by computing pairwise
Wright’s Fst index for each SNP of the complete reference
dataset. Distributions of Fst values obtained by comparing
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the genome reported in the 1000 Genomes Project dataset
[39] were finally used to identify SNPs at the sequenced
genes showing unusual high differentiation with respect to
genomic patterns (i.e., with Fst scoring in the 99th percen-
tiles of the obtained genome-wide distributions).
Basic descriptive and neutrality statistics
Full-gene sequence data for candidate genes pointed out
by differentiation analyses were used to compute basic
descriptive and neutrality statistics for NCWS and refer-
ence continental groups of populations. Accordingly,
estimates of nucleotide diversity as the average number of
pairwise differences (π), number of segregating sites (S),
Tajima’s D (D), and Fu and Li’s D and F (D′, F) were calcu-
lated by using the DnaSP package v.5.10 [40]. Significance
of these statistics was assessed by one-tailed tests aimed at
comparing them with distributions of values obtained by
performing 10,000 coalescent simulations conditioned on
local recombination and mutation rates and assuming a
neutral model of evolution. Adjusted p values for the
adaptive Benjamini and Hochberg (ABH) procedure [41]
were computed using the R package multtest to control
the false discovery rate (FDR) at α = 0.01.
Linkage disequilibrium and haplotype analyses
The PLINK package v.1.07 [37] was used to calculate pair-
wise LD for each SNP pair retrieved from the 1000
Genomes Project dataset [36] and included in the gen-
omic interval covering the best candidate genes pointed
out by neutrality tests, as well as their 100-kb upstream
and downstream regions.
SNPs in high LD (r2 > 0.95) with the most promising
candidate variants were used to statistically infer haplo-
types from unphased genotypes using the Bayesian algo-
rithm implemented in the PHASE software v.2.1 [42].
A median-joining network was used to explore evolution-
ary relationships among inferred haplotypes [43] by means
of the Network package v.4.6.1.2 (http://www.fluxus-engi
neering.com). The same software was used to estimate time
to the most recent common ancestor (TMRCA) using a
phylogeny-based approach and a mutation rate based on
the number of fixed differences between human samples
and the chimpanzee, assuming 6 My as the divergence time
between the two species [44].
Results
Sequence variability of the NCWS sample
Two amplicon-based massive parallel sequencing runs
were performed on an Ion PGM™ platform to characterize
profiles of 18 NCWS subjects at a 14.8-kb genomic inter-
val including CXCR3, CXCL9, CXCL10, and CXCL11
genes, as well as their promoter and untranslated regions.
Respectively, 95 and 98 % of sequence reads that passedQC filters mapped to the target genes, leading to an aver-
age sequencing coverage of 407×.
A total of 48 different sequence variants were identified
in the whole sample, 94 % of which were SNPs already
annotated on the dbSNP database (build 137), while only
3 were small INDELs. Details of the sequence profiles for
each NCWS subject are reported in Additional file 2:
Table S1. On the whole, a single intronic SNP (rs2280964)
was observed in seven disease individuals on the gene en-
coding the CXCR3 chemokine receptor that binds gliadin
and represents the keystone of the investigated inflamma-
tory pathway. This is in line with the narrow variability
reported for this locus in the surveyed healthy populations
pointing to remarkable conservation of its nucleotide
sequence, and plausibly functional properties, also in the
disease phenotype, indicating unlikely involvement in
NCWS etiology (Additional file 3). Six, 18, and 23 variants
were instead observed on CXCL9, CXCL10, and CXCL11,
respectively. Both recurrent variants shared among most
samples and private ones were identified (Additional file
2: Table S1), with 34 sequence changes (i.e., 32 SNPs and
2 INDELs) being present in 12 disease subjects and 14
(i.e., 13 SNPs and one INDEL) being differently shared by
a minimum of 3 to a maximum of 9 individuals. Minor
alleles of rs143824398 and rs35795399 were finally ob-
served only once in the total sample.
Population structure
To depict worldwide patterns of variation at the most
informative genes (i.e., CXCL9, CXCL10, CXCL11), DAPC
was applied on sequence data retrieved for nine human
groups belonging to the 1000 Genomes Project dataset.
When single populations were used as pre-defined groups
of individuals, no clear distinction among the four EUR
samples, as well as among the three EAS ones, was
detectable along the first two linear discriminants that
mainly described the largest between-group variance and
the smallest within-group one. Only AFR populations
seemed to be not completely overlapped with each other
(Additional file 4: Figure S2).
A more consistent structure appeared to be evident at a
lower geographical resolution, so that DAPC was repeated
using continental clusters of populations as pre-defined
groups of observations. Although partial overlap between
clusters of samples with different origins was still detect-
able, as confirmed by computed posterior membership
probabilities (Additional file 5: Figure S3), nearly homoge-
neous intra-continental genetic landscapes were observed,
especially as regards EUR and EAS, together with appre-
ciable divergence between individuals with predominant
AFR, EUR, and EAS ancestries. In fact, 79 % of examined
African subjects showed posterior probabilities consistent
with their affiliation to AFR, while 18 and 2 % of them are
clustered within EUR and EAS groups. Similarly, DAPC
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17 and 7 % of them more plausibly belonged to EAS and
AFR clusters. Finally, 83 % of East Asian subjects showed
posterior probabilities consistent with their affiliation to
EAS, while the remaining 17 % was assigned to EUR.
To contextualize NCWS genetic profiles into observed
worldwide variation patterns, position of disease individuals
along the computed linear discriminants was predicted
using the model fitted on the reference dataset. Accord-
ingly, 72 % of NCWS samples showed posterior probabil-
ities consistent with their affiliation to EUR, while 28 %
more plausibly belonged to the EAS cluster, a greater, but
not significantly increased value in comparison with that
obtained for EUR (Fisher’s exact test p = 0.212).
Unusually differentiated loci
To point out SNPs that mainly drive divergence between
observed clusters of genetically homogeneous populations,
pairwise Fst was calculated for each nucleotide position at
the examined genes and compared with genome-wide Fst
distributions obtained for the same continental compari-
sons. Three CXCL9 SNPs, as well as 11 CXCL10 and 16
CXCL11 ones, were highlighted as loci showing exception-
ally high differentiation and quite similar patterns of
derived allele frequency (DAF). The most outlier Fst values
and the highest DAF differences (0.44–0.46) were found
between EUR and EAS (Additional file 6: Table S2). More-
over, derived alleles of these SNPs turned out to be nearly
absent (e.g., DAF = 0.06) or fixed (e.g., DAF = 0.94) in
EAS, while at intermediate frequency (i.e., DAF ranging
from 0.48 to 0.52) in both EUR and NCWS, suggesting
that profoundly different demographic or selective forces
have acted on these groups.
Signatures of natural selection at the examined genes
To test whether observed DAF patterns have been actually
shaped by natural selection, estimates of genetic diversity
and site frequency spectrum-based statistics were com-
puted on candidate genes pointed out by differentiation
analysis using whole-gene sequence data.
After correction for multiple testing, no significant results
were obtained for CXCL9, which showed few variants, in
accordance with modest levels of polymorphism character-
izing human groups of different ancestry (Table 1), and
worldwide nucleotide diversity substantially lower with re-
spect to what were observed for the other two CXCR3
ligands. Progressive reduction of variability and number of
segregating sites from African to non-African populations,
coupled with non-significant results obtained by neutrality
tests, suggests that CXCL9 recent evolutionary history was
mainly shaped by demographic and admixture events,
rather than by natural selection so that the hypothesis of
the past CXCL9-driven adaptive events responsible for
present-day NCWS epidemiological patterns could be ruledout. One-tailed tests for comparison of computed values
with distributions of simulated ones instead pointed out
unusual diversity and neutrality statistics for CXCL10 and
CXCL11, suggesting appreciable departures of their allele
frequency spectra from patterns expected under neutral
evolution. An exceptional increase in EUR nucleotide
diversity was observed for both genes (π = 15.8 × 10−4,
ABH adjusted p = 0.008 and π = 29 × 10−4, ABH adjusted
p = 0.003), and comparable results were obtained also for
NCWS (π = 16.8 × 10−4, ABH adjusted p = 0.007 for
CXCL10 and π = 28.9 × 10−4, ABH adjusted p = 0.0006 for
CXCL11). Moreover, significant and largely positive
Tajima’s D values were found for disease and healthy EUR
samples for both CXCL10 (EUR D = 2.608, ABH adjusted
p = 0.008 and NCWS D = 2.442, ABH adjusted p = 0.007)
and CXCL11 (EUR D = 2.822, ABH adjusted p = 0.002 and
NCWS D = 3.072, ABH adjusted p = 0.0004). Significant
and consistently positive values were observed in NCWS
also at CXCL10 for Fu and Li’s F statistic (F = 2.007, ABH
adjusted p = 0.008) and at CXCL11 for Fu and Li’s D and F
tests (D′ = 1.832, ABH adjusted p < 0.0001; F = 2.716,
ABH adjusted p = 0.0003). A single result remained
significant after ABH correction at CXCL11 also for
AFR (D′ = 1.683, ABH adjusted p = 0.004).
Haplotype structure
LD patterns were investigated in a genomic interval
covering candidate regions highlighted by neutrality tests,
as well as their 100-kb upstream and downstream se-
quences, to detect possible functional loci located outside
CXCL10 and CXCL11, but responsible for the observed
signatures of natural selection. A large LD block (39 kb)
was found to include all SNPs showing unusual differenti-
ation with respect to genomic patterns. When pairwise
LD values were calculated, these variants turned out to be
in extremely high LD (r2 > 0.95) only with each other and
with none of the remaining 2898 SNPs located within the
extend examined region, suggesting the highly plausible
adaptive role played by some of them in EUR.
Haplotypes were reconstructed for this region of tight
LD and their distributions in the studied groups were
visualized by means of a median-joining network. A
phylogeny characterized by ten haplotypes structured in
two main clades (a and b) showing deep coalescence
time (i.e., TMRCA of 1.4–1.7 My) was observed (Fig. 1).
Despite overall high LD, rs4619915, rs4859588, rs4241578,
and rs6819597 turned out to be recurrent, respectively,
within the a and b branches of the topology, while the
other three SNPs were observed in both of them. In
particular, rs3921 and rs6825045 characterized all clade a
haplotypes and the low frequency H5 and H9 clade b
haplotypes, respectively. On the contrary, rs10025102 was
found in all haplotypes of branch b, being present only in
the singleton AFR branch a H3 haplotype. All these
Table 1 Basic descriptive and neutrality statistics for the examined candidate genes
Gene Sample N S π (×10−4) D D′ F
CXCL9 (6.4 kb) AFR 492 40 4.5 (0.992) −1.403 (0.007) −0.037 (0.568) −0.800 (0.169)
EAS 572 18 2.8 (0.838) −0.766 (0.158) −0.253 (0.493) −0.562 (0.136)
EUR 758 16 3.7 (0.329) 0.1504 (0.621) −1.371 (0.154) −0.859 (0.179)
NCWS 36 6 3.7 (0.026) 1.734 (0.025) 0.382 (0.206) 0.950 (0.176)
CXCL10 (4 kb) AFR 492 32 13.3 (0.259) 0.348 (0.289) −0.643 (0.332) −0.202 (0.440)
EAS 572 26 6.6 (0.741) −0.746 (0.252) −1.146 (0.198) −1.185 (0.136)
EUR 758 22 15.8 (0.009) 2.608 (0.006) 0.608 (0.104) 1.772 (0.025)
NCWS 36 16 16.8 (0.003) 2.442 (0.003) 1.266 (0.105) 2.007 (0.009)
CXCL11 (3.5 kb) AFR 492 34 24.2 (0.040) 1.827 (0.032) 1.683 (0.006) 2.080 (0.010)
EAS 572 28 13.8 (0.762) 0.492 (0.247) 1.446 (0.018) 1.277 (0.082)
EUR 758 35 29.0 (0.005) 2.822 (0.002) −0.127 (0.466) 1.396 (0.056)
NCWS 36 22 28.9 (0.0006) 3.072 (0.0001) 1.832 (0.0001) 2.716 (0.0002)
In brackets, p values obtained by 10,000 coalescent simulations conditioned on local recombination and mutation rates
Numbers in italics are the results significant after ABH correction for multiple testing to control FDR at α = 0.01
N number of chromosomes, S number of segregating sites, π nucleotide diversity, D Tajima’s D, D′ Fu and Li’s D, F Fu and Li’s F, AFR Africans, EAS East Asians,
EUR Europeans, NCWS Italian individuals affected by non-celiac wheat sensitivity
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the results of recombination or gene conversion events
which occurred at the examined regions.
Most of the inferred haplotypes showed extremely low
frequencies (up to 4.3 %) in all continental groups,Fig. 1 Median-joining network of haplotypes made up of SNPs unusually d
LD (r2 ≥ 0.95). AFR are displayed in blue, EAS in green, EUR in red, and NCW
branch lengths are proportional to the number of variants that occurred insuggesting that they have been unlikely favored by natural
selection. The sole exceptions were haplotypes H1, belong-
ing to clade a, and H10 belonging to clade b, which
accounted for approximately 96 % of sampled chromo-
somes, being distributed in all the examined groups. Inifferentiated among continental population clusters and showing high
S in black. Nodes are proportional to haplotype frequencies, while
the sequences
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and NCWS (53 %), whereas it showed moderate frequen-
cies in AFR and EAS (21 and 6 %, respectively). It carried
derived alleles at 14 SNPs, 71 % of them being located
within 3′ UTR of CXCL10 and CXCL11 (Additional file 6:
Table S2), thus potentially exerting a regulatory function on
their expression. On the contrary, H10 represented the
major haplotype in AFR (68 %) and EAS (92 %), reaching
lower, but still remarkable frequencies in EUR (48 %) and
NCWS (47 %). It carried derived alleles at the other 16 un-
usually differentiated SNPs, with most of them being lo-
cated within intronic regions.
Discussion
The present study investigated the genetic legacy of
natural selection on genes plausibly involved in the de-
velopment of NCWS to shed light on the evolutionary
bases of its present-day epidemiological patterns. In fact,
high disease prevalence in Western populations [3, 6]
suggests that different selective pressures could have
acted on its main genetic determinants in diverse human
groups. In particular, it can be hypothesized that new
immune-stimulatory epitopes introduced in the human
diet by recent replacement of ancient wheat with modern
dwarf varieties highly selected for improving industrial
productivity [13, 26] turned adaptive alleles previously
maintained by natural selection in the European gene pool
into disadvantageous ones. This sudden dietary shift might
have thus triggered a maladaptive process underlying in-
creased NCWS susceptibility of Western people.
According to this rationale, genes pivotal in the CXCR3-
inflammatory pathway were sequenced in 18 Italian NCWS
subjects to carry out an explorative research not aimed at
performing a traditional genetic association study, but at
providing new insights into NCWS evolutionary history.
We are aware of the small number of patients enrolled,
nevertheless, since even limited sample sizes enable to
evaluate individuals’ genetic ancestry and possible signa-
tures of natural selection through population genetics
methods, we aimed at including in this study only well-
characterized disease subjects for which CD and WA were
certainly excluded by immunological and clinical tests.
Moreover, these patients were also selected by considering
clinical onset and follow-up that clearly documented drastic
resolution of symptoms after a gluten-free diet and their
rapid reappearance after reintroduction of wheat in the
dietary regimen. This approach enabled to detect remark-
able amounts of highly polymorphic CXCL10/CXCL11 var-
iants in NCWS and healthy EUR, resulting in diversity
levels substantially higher with respect to CXCL9 ones
(Table 1). Variation at these genes also turned out to be the
main determinant of population structure depicted by
DAPC (Additional file 5: Figure S3) and could be inter-
preted as the combined result of similar demographicprocesses and environmental selective pressures experi-
enced by populations belonging to close geographical areas.
Largely shared genetic background for EUR healthy and
disease individuals was indeed confirmed by DAPC mem-
bership probabilities (Additional file 5: Figure S3), suggest-
ing the absence of highly penetrant causative mutations
affecting CXCR3 axis in the latter group. In particular,
divergence between continental population clusters was
driven by 30 high-LD common SNPs mainly located on
CXCL10 and CXCL11 and exhibiting comparable DAFs in
NCWS and EUR (Additional file 6: Table S2 and Additional
file 3). Since under a neutral model of evolution demo-
graphic and evolutionary forces simultaneously affecting all
loci of the genome (e.g., admixture and genetic drift) are
expected to determine Fst values, these highly differentiated
SNPs could be considered as variants with potential
relevant functional effects and that might be subjected
to differential selective pressures in diverse popula-
tions [45, 46]. In fact, null hypothesis of neutral evo-
lution was rejected by site frequency spectrum-based
tests for CXCL10 and CXCL11, which showed signifi-
cant excess of intermediate frequency alleles in EUR
and NCWS (Table 1 and Additional file 3). Therefore,
disease variation turned out to be in line with that of
healthy individuals with comparable ancestry, being mainly
characterized by common polymorphisms. Although pau-
city of rare alleles could be partly due to the limited NCWS
sample size (i.e., to reduced probability to detect rare
sequence changes), it might be also interpreted as a first
clue suggesting that increased NCWS susceptibility is not
due to deleterious variants scarcely represented in the over-
all population. Described departures of CXCL10/CXCL11
allele frequency spectra from those expected under neutral-
ity can result from ancient population structure or the ac-
tion of balancing selection [47–50]. Despite truly significant
neutrality scores were obtained almost exclusively in EUR,
overall positive or moderately negative values were anyway
observed also for AFR and EAS, especially for CXCL11
(Table 1). These findings appear to be not consistent with
geographically restricted population structure, rather sug-
gesting a generalized tendency of most human groups to
maintain high polymorphism most likely due to ancient
selective events. More recent and stronger episodes of
balancing selection could have subsequently occurred only
in EUR, as previously described for other genes involved in
innate immunity [51, 52], making a frequency spectrum
already skewed towards intermediate alleles even more
extreme and leading to the observed EUR unusual diversity
and neutrality statistics. When haplotype genealogies were
inferred at the region of tight LD encompassing CXCL10
and CXCL11 most differentiated SNPs, two highly diver-
gent haplotype clusters were observed (Fig. 1), corroborat-
ing the hypothesis that increased EUR diversity was
maintained by balancing selection [53–55]. Two common
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counting for the vast majority of sampled chromosomes
and hence representing the most likely adaptive allelic
combinations (Additional file 7: Table S3). H1 was over-
represented in NCWS (53 %) and EUR (50 %) in compari-
son to AFR (21 %) and EAS (6 %), whereas H10 showed the
opposite pattern. While most derived alleles characterizing
H10 lie within intronic regions, the great majority of those
carried by H1 were located at 3′ UTRs (Additional file 6:
Table S2), thus having the potential to substantially affect
mRNA stability/translation efficiency and possibly leading
to de-regulation of post-transcriptional expression [56, 57].
In detail, rs8878-derived allele was found to significantly en-
hance CXCL10 translation by increasing its mRNA half-life
[18]. CXCL10 overexpression was demonstrated to be me-
diated also by rs3921-derived allele in patients affected by
multiple sclerosis [58], invasive asperigillosis [59], and
hematological malignancies [60]. Derived allele at rs3921
and CXCL9 rs10336 also turned out to boost CXCR3 ex-
pression, in addition to that of the respective genes, in pa-
tients with severe progression of Chagas cardiomyopathy
[19]. In line with these findings, CXCL10 overexpression
has been clearly proved in mononucleated cells extracted
from NCWS patients exposed to wheat proteins [13]. These
observations confirmed the proposed immune-modulatory
role of these chemokines on the whole CXCR3 axis [61],
pointing them as the master regulators of chemokine-
dependent inflammatory processes. Therefore, maintenance
of comparable proportions of H1 and H10 by balancing
selection mainly in EUR might have been triggered by
selective pressures related to the recurrent epidemics that
have plagued Europeans, especially after increase in demo-
graphic density and adoption of animal domestication
consequent to Neolithic transition [22]. This would have
thus enabled concurrent presence in the European gene
pool of both alleles able to boost inflammatory reactions
and alleles responsible for moderate chemokines expression.
A subtle evolutionary balance between aggressive responses
to pathogens (which favor the health of individuals) and
their potential side effects (which result in disease pheno-
types) was thus established, enabling the maintenance of
proper inflammatory defenses. Departures from this condi-
tion of equilibrium due to the disruptive impact of modern
diet-related immune-stimulatory epitopes have then
recently entailed increased susceptibility to inflammatory
diseases for a considerable fraction of EUR subjects. Inter-
estingly, while overall H1 frequency is slightly higher in
NCWS (53 %) than in healthy Italians (TSI, 45 %), distribu-
tion of H1 homozygotes is even more different between
them, with NCWS showing a more than twofold percentage
in comparison to TSI. However, since the limited number
of sequenced subjects prevents to perform reliable genetic
association tests, genotyping experiments targeted to the
most informative H1 SNPs could be carried out on aconsiderably larger disease sample to test an additive model
for H1 contribution to increased NCWS susceptibility [62].
In fact, whether typical European H1 heterozygotes
present enhanced CXCR3 axis expression with respect
to H10 homozygotes, which are the most common con-
dition in worldwide human groups, H1 homozygotes might
have an even more augmented chemokine expression that
could confer them a further increase in NCWS risk.Conclusions
The adopted anthropological evolutionary genetics perspec-
tive enabled to set NCWS variation at the CXCR3 axis into
the genetic landscape of healthy individuals with compar-
able ancestry. Coupled with reconstruction of the evolu-
tionary history of these candidate genes in worldwide
populations, it provided an effective evolutionary medicine
approach disentangling the role of different environmental/
cultural factors in making populations of European
ancestry more prone to develop NCWS possibly as a conse-
quence of complex gene-environment interactions, such as
that represented by recent introduction of modern wheat
varieties in Western diets. Further genotyping experiments
targeted to the most informative SNPs pinpointed by the
present study and to additional loci involved in CD and
wheat-related syndromes should be carried out on consid-
erably larger NCWS samples to corroborate such an
hypothesis, together with gene expression studies aimed at
clarifying which of the examined genes actually represents
the driver of CXCR3 axis overexpression in this patho-
logical condition.Additional files
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